Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13618973 | 0.91 | BTK (0.37) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL13618997 | 0.91 | BTK (0.37) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL13631330 | 0.91 | BTK (0.37) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL30880111 | 0.88 | MMP2 (0.30) | — | |
| SCHEMBL13696126 | 0.87 | BTK (0.51) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL15016060 | 0.87 | BTK (0.51) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL15016061 | 0.87 | BTK (0.51) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL13618937 | 0.86 | BTK (0.39) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL13618940 | 0.86 | BTK (0.39) | BTKMAOBMAOAKDM1ASYK | |
| SCHEMBL16664797 | 0.82 | BTK (0.36) | BTKMAOBMAOAKDM1ASYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4438592-B1 | EDOXABAN INTERMEDIATE AND PREPARATION METHOD THEREFOR | SHANGHAI BIOS TECH CO LTD (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4438592-A1 | EDOXABAN INTERMEDIATE AND PREPARATION METHOD THEREFOR | Shanghai Bios Technology Co., Ltd. (CN) | 2024-10-02 | — | — | EP | disclosed |
| WO-2024092892-A1 | EDOXABAN INTERMEDIATE AND PREPARATION METHOD THEREFOR | 上海柏狮生物科技有限公司 | 2024-05-10 | — | — | WO | disclosed |